Skip to content
No results
  • Account
  • crm
  • femto chooser
  • Home
  • Login
  • NEWS
  • test
  • trading
  • Account
  • crm
  • femto chooser
  • Home
  • Login
  • NEWS
  • test
  • trading
  • stocks

NUKZ Caught the Nuclear Restart Wave but Holds Less Than $1 Billion in Assets, and That Liquidity Cliff Matters

NUKZ Caught the Nuclear Restart Wave But Holds Less Than $1 Billion in Assets, And That Liquidity Cliff Matters Quick Read - Range Nuclear Renaissance Index ETF (NUKZ) has delivered a 53% one-year gain but carries a 0.85% expense ratio and holds only $870M in assets, creating...<

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

Exxon Mobil (XOM) in Talks to Re-enter Venezuela after Nearly Two Decades

Exxon Mobil Corporation (NYSE:XOM) is included among the 12 Best LNG Stocks to Buy in 2026. Exxon Mobil Corporation (NYSE:XOM) is one of the largest integrated fuels, lubricants, and chemical companies in the world A New York Times report on May 21 revealed that Exx

  • mohammad501ps@gmail.com
  • May 26, 2026
  • central_banks

New Fed Chairman Kevin Warsh Wants to Break 2 FOMC Practices from the Last 15 Years, and It Could be Bad News for Stock

New Fed Chairman Kevin Warsh Wants to Break 2 FOMC Practices From the Last 15 Years, and It Could Be Bad News for Stock Investors Kevin Warsh plans to shake up the Federal Reserve under his chairmanship. Not only is he coming in with a monetary policy agenda that could dep

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

MSGS Shares Rise 3% Premarket as Knicks Reach NBA Finals

Madison Square Garden Sports stock climbs after the New York Knicks advance to the NBA Finals for the first time since 1999. Madison Square Garden Sports (MSGS) shares rose 3% in premarket trading after the New York Knicks secured a spot in the NBA Finals for the first tim

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

Cuts Canaccord PT on Regeneron Pharmaceuticals (regn), Cites a Disappointing Event

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best medical stocks to invest in according to billionaires. Canaccord cut the price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $875 from $1,057 on May 19, maintaining a Buy rating on the shares

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

Salesforce (CRM) Dropped Nearly 20% Due to AI Disruption Concerns

In its first-quarter 2026 investor letter, Artisan Value Fund highlighted stocks like Salesforce, Inc. (NYSE:CRM). Salesforce, Inc. (NYSE:CRM) is a cloud computing company that offers Customer Relationship Management (CRM) technology that brings companies and customers tog

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

Bernstein Lifts PT on Arrowhead Pharmaceuticals (arwr) Following Biotech’s Solid Start to 2026

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is one of the best medical stocks to invest in according to billionaires. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) received a rating update from Bernstein on May 13 The firm lifted the price target on the stock to $

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

Ex-bankers Charge $25,000 a Day to Teach Wall Street AI

Felipe Sinisterra and Dave Wang, two former SoftBank fund managers, are charging financial institutions $25,000 a day to train bankers and analysts on artificial intelligence tools — and they are booked two months out, according to Bloomberg. The pair founded Wall Street P

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

Is Pfizer Inc. (PFE) One of the Best Medical Stocks to Invest in According to Billionaires?

Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to invest in according to billionaires. Pfizer Inc. (NYSE:PFE) announced on May 20 data from its Phase 2 study evaluating the safety, tolerability, and immunogenicity of a four-dose series of its investigational 25-v

  • mohammad501ps@gmail.com
  • May 26, 2026
  • stocks

Morgan Stanley, Bernstein Raise CVS Price Targets to $106 on Medicare Advantage Outlook

Two major firms lifted CVS Health’s price target citing reduced PBM reform uncertainty and stable earnings potential in key segments. Morgan Stanley and Bernstein increased their price targets for CVS Health (NYSE:CVS) to $106 from $93 and $94, respectively, maintaining bu

  • mohammad501ps@gmail.com
  • May 26, 2026
Prev
1 … 4,218 4,219 4,220 4,221 4,222 4,223 4,224 … 6,179
Next
Copyright © 2026 - WordPress Theme by CreativeThemes

سجّل دخولك للمشاركة

ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.

Continue with Google

إيميلك يبقى موثّقاً وخصوصيتك محفوظة.